Véronique Dalstein

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Brain Metastases

Top Venues

Life (Basel, Switzerland)

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life (Basel, Switzerland) 14 (1) (2023)
Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life (Basel, Switzerland) 14 (1) (2023)
Emma Loeffler, Julien Ancel, Véronique Dalstein, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. Life (Basel, Switzerland) 14 (1) (2023)
Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf, Claire Launois, Pauline Mulette, Béatrice Nawrocki-Raby, Véronique Dalstein, Christine Gilles, Gaëtan Deslée, Myriam Polette, Valérian Dormoy
Hypoxia in Lung Cancer Management: A Translational Approach. Cancers 13 (14) (2021)
Sylvie Brassart-Pasco, Véronique Dalstein, Bertrand Brassart, Maxime Dewolf, Christine Clavel, Jean-Baptiste Oudart
Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patterns. Pharmacogenomics 21 (10) (2020)
Julien Ancel, Philippe Birembaut, Maxime Dewolf, Anne Durlach, Béatrice Nawrocki-Raby, Véronique Dalstein, Gonzague Delepine, Silvia Blacher, Gaëtan Deslée, Christine Gilles, Myriam Polette
Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC. Cancers 11 (10) (2019)